| 1. |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester
|
EGF
|
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [EGF protein affects the localization of PRKCB protein] |
1 |
1 |
| 2. |
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine
|
EGF
|
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] |
3 |
1 |
| 3. |
2',3,3',4',5-pentachloro-4-hydroxybiphenyl
|
EGF
|
2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of EGF mRNA |
1 |
1 |
| 4. |
2,4-dinitrotoluene
|
EGF
|
2,4-dinitrotoluene affects the expression of EGF mRNA |
1 |
1 |
| 5. |
2,6-dinitrotoluene
|
EGF
|
2,6-dinitrotoluene affects the expression of EGF mRNA |
1 |
1 |
| 6. |
3,4,5,3',4'-pentachlorobiphenyl
|
EGF
|
3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of EGF mRNA |
1 |
1 |
| 7. |
3,5,3',4',5'-pentahydroxy-stilbene
|
EGF
|
3,5,3',4',5'-pentahydroxy-stilbene inhibits the reaction [EGF protein results in increased activity of PIK3R1 protein] |
1 |
|
| 8. |
3,5,3',4',5'-pentahydroxy-stilbene
|
EGF
|
3,5,3',4',5'-pentahydroxy-stilbene results in decreased susceptibility to EGF protein |
1 |
|
| 9. |
4,4'-diaminodiphenylmethane
|
EGF
|
4,4'-diaminodiphenylmethane results in decreased expression of EGF mRNA |
2 |
2 |
| 10. |
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
|
EGF
|
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Cisplatin]] |
1 |
1 |
| 11. |
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
|
EGF
|
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to gemcitabine]] |
1 |
1 |
| 12. |
4,5-dianilinophthalimide
|
EGF
|
4,5-dianilinophthalimide inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone] |
1 |
1 |
| 13. |
4-hydroxytamoxifen
|
EGF
|
[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 mRNA |
1 |
1 |
| 14. |
4-hydroxytamoxifen
|
EGF
|
[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 protein |
1 |
1 |
| 15. |
4-hydroxytamoxifen
|
EGF
|
AG 1879 inhibits the reaction [[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 protein] |
1 |
1 |
| 16. |
4-hydroxytamoxifen
|
EGF
|
fulvestrant inhibits the reaction [[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 protein] |
1 |
1 |
| 17. |
4-hydroxytamoxifen
|
EGF
|
PD 98059 inhibits the reaction [[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 protein] |
1 |
1 |
| 18. |
4-tert-octylphenol
|
EGF
|
4-tert-octylphenol results in increased expression of EGF mRNA |
1 |
1 |
| 19. |
6-chrysenamine
|
EGF
|
6-chrysenamine inhibits the reaction [EGF protein binds to EGFR protein] |
1 |
1 |
| 20. |
Acetaldehyde
|
EGF
|
chelerythrine inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]] |
1 |
1 |
| 21. |
Acetaldehyde
|
EGF
|
chelerythrine inhibits the reaction [EGF protein results in decreased susceptibility to Acetaldehyde] |
1 |
1 |
| 22. |
Acetaldehyde
|
EGF
|
EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein] |
1 |
1 |
| 23. |
Acetaldehyde
|
EGF
|
EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein] |
1 |
1 |
| 24. |
Acetaldehyde
|
EGF
|
EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin] |
1 |
1 |
| 25. |
Acetaldehyde
|
EGF
|
EGF protein results in decreased susceptibility to Acetaldehyde |
1 |
1 |
| 26. |
Acetaldehyde
|
EGF
|
PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein]] |
1 |
1 |
| 27. |
Acetaldehyde
|
EGF
|
PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]] |
1 |
1 |
| 28. |
Acetaldehyde
|
EGF
|
PRKCB protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]] |
1 |
1 |
| 29. |
Acetaldehyde
|
EGF
|
PRKCB protein affects the reaction [EGF protein results in decreased susceptibility to Acetaldehyde] |
1 |
1 |
| 30. |
Acetaldehyde
|
EGF
|
PRKCE protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]] |
1 |
1 |
| 31. |
Acetaldehyde
|
EGF
|
PRKCE protein affects the reaction [EGF protein results in decreased susceptibility to Acetaldehyde] |
1 |
1 |
| 32. |
Acetaldehyde
|
EGF
|
Ro 32-0432 inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]] |
1 |
1 |
| 33. |
Acetaldehyde
|
EGF
|
Ro 32-0432 inhibits the reaction [EGF protein results in decreased susceptibility to Acetaldehyde] |
1 |
1 |
| 34. |
2-Acetylaminofluorene
|
EGF
|
2-Acetylaminofluorene affects the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
1 |
1 |
| 35. |
2-Acetylaminofluorene
|
EGF
|
2-Acetylaminofluorene results in decreased localization of EGF protein |
1 |
1 |
| 36. |
Acetaminophen
|
EGF
|
[EGF protein co-treated with HGF protein] promotes the reaction [Acetaminophen results in decreased expression of CYP1A2 mRNA] |
1 |
1 |
| 37. |
Acetylcysteine
|
EGF
|
Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine] |
1 |
1 |
| 38. |
Acetylcysteine
|
EGF
|
Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of Peroxides] |
1 |
1 |
| 39. |
allylpyrocatechol
|
EGF
|
allylpyrocatechol promotes the reaction [Indomethacin results in increased expression of EGF protein] |
1 |
1 |
| 40. |
alpha-hexachlorocyclohexane
|
EGF
|
[EGF protein co-treated with alpha-hexachlorocyclohexane] results in increased expression of MYC mRNA |
1 |
1 |
| 41. |
Ethanolamine
|
EGF
|
Ethanolamine results in increased activity of EGF protein |
1 |
1 |
| 42. |
amphotericin B, deoxycholate drug combination
|
EGF
|
amphotericin B, deoxycholate drug combination results in decreased expression of EGF mRNA |
1 |
1 |
| 43. |
anacardic acid
|
EGF
|
anacardic acid results in decreased susceptibility to EGF protein |
1 |
1 |
| 44. |
anthra(1,9-cd)pyrazol-6(2H)-one
|
EGF
|
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Cisplatin]] |
1 |
1 |
| 45. |
anthra(1,9-cd)pyrazol-6(2H)-one
|
EGF
|
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to gemcitabine]] |
1 |
1 |
| 46. |
anthra(1,9-cd)pyrazol-6(2H)-one
|
EGF
|
anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [EGF protein results in increased expression of CDKN1A mRNA] |
1 |
1 |
| 47. |
arsenic trioxide
|
EGF
|
arsenic trioxide results in increased expression of EGF mRNA |
1 |
1 |
| 48. |
arsenite
|
EGF
|
SB 203580 results in decreased activity of [arsenite co-treated with EGF protein] |
1 |
1 |
| 49. |
benz(a)anthracene
|
EGF
|
AHR protein affects the reaction [benz(a)anthracene inhibits the reaction [EGF protein binds to EGFR protein]] |
1 |
1 |
| 50. |
benz(a)anthracene
|
EGF
|
benz(a)anthracene inhibits the reaction [EGF protein binds to EGFR protein] |
1 |
1 |